PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
US$ 8.50
0.00%
(0.00) Siku 1
12 Okt, 10:22:09 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya PTKFY...
Mtaji wa soko
29.49T
Wastani wa kiasi cha mauzo
elfu 1.94
Kiasi cha mauzo ya hisa
elfu 1.43
Juu kwa wiki 52
US$ 16.36
Chini kwa wiki 52
US$ 7.63
Beta
0.09
Hisa za wawekezaji
234.07M
Idadi ya wafanyakazi
elfu 13
Mtaji wa soko
29.49T
Wastani wa kiasi cha mauzo
elfu 1.94
Kiasi cha mauzo ya hisa
elfu 1.43
Juu kwa wiki 52
US$ 16.36
Chini kwa wiki 52
US$ 7.63
Beta
0.09
Hisa za wawekezaji
234.07M
Idadi ya wafanyakazi
elfu 13
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 12 zilizopita
Kalbe Farma reports 6,000 health packages while Kalbe Farma stock trades at EUR 0.03
Wasifu
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Kuhusu PT Kalbe Farma Unsponsored Indonesia ADR
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 12.8
Lilianzishwa10 Sep 1966
Makao makuu-
Sekta-
Tovutikalbe.co.id